Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 12 · newest first

  1. Cardiotoxicity in breast cancer treatment: Causes and mitigationSHILAP Revista de lepidopterología · 2023
  2. Challenges in the management of colorectal cancer in low- and middle-income countriesSHILAP Revista de lepidopterología · 2023
  3. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced diseaseSHILAP Revista de lepidopterología · 2023
  4. The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinomaCancer Treatment and Research Communications · 2023
  5. MicroRNAs in exhaled breath condensate: A pilot study of biomarker detection for lung cancerCancer Treatment and Research Communications · 2023
  6. Identification of circulating tumour DNA (ctDNA) from the liquid biopsy results: Findings from an observational cohort studyCancer Treatment and Research Communications · 2023
  7. Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancerCancer Treatment and Research Communications · 2023
  8. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumorCancer Treatment and Research Communications · 2023
  9. Comparison of sequential versus simultaneous integrated boost of volumetric modulated arc therapy in treatment of oropharyngeal carcinomaCancer Treatment and Research Communications · 2023
  10. High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiologyCancer Treatment and Research Communications · 2023
  11. Factors associated with health seeking delay in the screening of cervical cancer among women in Imo state, south Eastern NigeriaCancer Treatment and Research Communications · 2023
  12. Human papilloma virus vaccines: A comprehensive narrative reviewCancer Treatment and Research Communications · 2023
  13. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysisCancer Treatment and Research Communications · 2023
  14. Pharmaceutical industry funding and chemotherapy trials for prostate cancer: A systematic reviewCancer Treatment and Research Communications · 2023
  15. Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancerCancer Treatment and Research Communications · 2023
  16. Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative studyCancer Treatment and Research Communications · 2023
  17. Molecular mechanisms investigation for liver metastasis of colorectal cancer by combined bioinformatic gene expression profile analysisCancer Treatment and Research Communications · 2023
  18. Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hopeCancer Treatment and Research Communications · 2023
  19. A low risk of recurrence after breast-conserving surgery for DCIS: A single-institution experienceCancer Treatment and Research Communications · 2023
  20. Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancerCancer Treatment and Research Communications · 2023
  21. 3-deazaadenosine: A promising novel p38γ antagonist with potential as a breast cancer therapeutic agentCancer Treatment and Research Communications · 2023
  22. Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centreCancer Treatment and Research Communications · 2023
  23. FAM111B dysregulation promotes malignancy in fibrosarcoma and POIKTMP and a low-cost method for its mutation screeningCancer Treatment and Research Communications · 2023
  24. G-CSF filgrastim biosimilar-Sandoz reduces the incidence of febrile neutropenia in patients receiving chemotherapy regimens with rest periods not exceeding 14 days: A French, multicenter, prospective, non-interventional studyCancer Treatment and Research Communications · 2023
  25. Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspectsCancer Treatment and Research Communications · 2023
  26. Insights into head and neck cancer research in Egypt: A scoping reviewCancer Treatment and Research Communications · 2023
  27. Compliance to adjuvant endocrine therapy and survival in breast cancer patients.Cancer Treatment and Research Communications · 2023
  28. Emerging frontiers in nanomedicine targeted therapy for prostate cancerCancer Treatment and Research Communications · 2023
  29. Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in advanced non-small cell lung cancerCancer Treatment and Research Communications · 2023
  30. Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancerCancer Treatment and Research Communications · 2023
  31. Right colon cancer: The influence of specific location on recurrence and survivalCancer Treatment and Research Communications · 2023
  32. Recent advances in the use of liquid biopsy to fight central nervous system tumorsCancer Treatment and Research Communications · 2023
  33. Implementing a mailed stool sample screening program in clinics providing care for an underserved Hispanic populationCancer Treatment and Research Communications · 2023
  34. The progresses of relevant factors on the efficacy of immune checkpoint inhibitors in the non-small cell lung cancer patientsCancer Treatment and Research Communications · 2023
  35. Thematic analysis of online discussion forums for soft tissue sarcomasCancer Treatment and Research Communications · 2023
  36. Safety evaluation of Datopotamab deruxtecan for triple-negative breast cancer: a meta-analysisCancer Treatment and Research Communications · 2023
  37. Disparities in lung cancer short- and long-term outcomes after surgery: Analysis from the national cancer databaseCancer Treatment and Research Communications · 2023
  38. Treatment of unresectable stage III NSCLC: Real world cohort study and literature reviewCancer Treatment and Research Communications · 2023
  39. The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patientsCancer Treatment and Research Communications · 2023
  40. Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging conceptCancer Treatment and Research Communications · 2023
  41. Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinomaCancer Treatment and Research Communications · 2023
  42. Metastatic pattern is a prognostic factor in BRAF mutant colorectal cancerCancer Treatment and Research Communications · 2023
  43. Predictive factors for nodal recurrence in differentiated thyroid cancersCancer Treatment and Research Communications · 2023
  44. Efficient drug delivery to lymph nodes by intradermal administration and enhancement of anti-tumor effects of immune checkpoint inhibitorsCancer Treatment and Research Communications · 2023
  45. Assessing Syrian women's knowledge of breast cancer risk factors, warning signs, and barriers to preventive measures: A cross-sectional studyCancer Treatment and Research Communications · 2023
  46. Insilco prediction of the role of the FriZZled5 gene in colorectal cancerCancer Treatment and Research Communications · 2023
  47. Evaluating the potential of immunotherapy and chemoimmunotherapy in the treatment of elderly non-small cell lung cancer patients: A real-world studyCancer Treatment and Research Communications · 2023
  48. A study on antimicrobial and anticancer properties of Cissus quadrangulris using lung cancer cell lineCancer Treatment and Research Communications · 2023
  49. Niclosamide in prostate cancer: An inhibitor of AR-V7, a mitochondrial uncoupler, or more?Cancer Treatment and Research Communications · 2023
  50. Cervical cancer screening in HIV-endemic countries: An urgent call for guideline changeCancer Treatment and Research Communications · 2023